Kirkland & Ellis represented Linden Capital Partners, Wilmer Cutler Pickering Hale and Dorr represented Alcresta Therapeutics and Wilson Sonsini Goodrich & Rosati advised HealthQuest Capital. Linden...
Linden Capital Partners’ Acquisition of Alcresta Therapeutics
Solid Biosciences’ $109 Million Private Placement
Wilmer Cutler Pickering Hale and Dorr advised Solid Biosciences Inc. on the deal. Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines...
Arvinas’ $350 Million Private Placement
Wilmer Cutler Pickering Hale and Dorr advised Arvinas, Inc. on the transaction. Arvinas, Inc. (Nasdaq: ARVN) (“Arvinas”) announced that it entered into a securities purchase agreement with a...
Inozyme Pharma’s Common Stock Public Offering
Wilmer Cutler Pickering Hale and Dorr represented Inozyme Pharma and Shearman & Sterling represented the underwriters in the offering. Inozyme Pharma, Inc. announced the closing of its...
Rakuten’s $1 Billion Acquisition of Altiostar Networks
Wilmer Cutler Pickering Hale and Dorr advised Altiostar on the deal. Rakuten Group, Inc., a leading global innovation company in e-commerce, communications and fintech, and operator...